Close Menu

NEW YORK, Oct. 2 – GeneChip-maker Affymetrix (Nasdaq: AFFX) of Santa Clara Calif., said Monday that it would acquire privately-held computational genomics company Neomorphic of Berkeley, Calif., for about $70 million in stock, based on Friday’s close.

The companies anticipate that products resulting from the acquisition will include whole-genome, high-density GeneChip arrays, new data analysis tools, and a series of Internet-accessible information products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.